Growth Factor Expression, Healing, and Structural Characteristics of Graftskin (Apligraf®)

Wounds

Volumn 12, Issue 5 SUPPL. A, 2000, Pages

  Milstone, Leonard M ^a,b   Asgari, Maryam M ^a,b   Schwartz, Pauline M ^a,b   Hardin Young, Janet ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c ORGANOGENESIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003126758     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Garlick JA, Taichman LB. Effect of TGF-beta 1 on re-epithelialization of human keratinocytes in vitro: An organotypic model. J Invest Dermatol 1994;103:554-9.
2. Apligraf® (Graftskin). In: Physicians' Desk Reference, 54th Edition. Montvale, NJ: Medical Economics Company Inc., 2000:1996-8.
3. Eaglstein WH, Iriondo M, Laszlo K. A composite skin substitute (Graftskin) for surgical wounds: A clinical experience. Dermatol Surg 1995;21:839-43.
4. Falanga V, Margolis D, Alvarez O, et al., for the Human Skin Equivalent Investigators Group. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol 1998;134:293-300.
5. Hansbrough JF, Morgan J, Greenleaf G, et al. Evaluation of Graftskin composite grafts on full-thickness wounds on athymic mice. J Burn Care Rehabil 1994;15:346-53.
6. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-4.
7. Declair V. The importance of growth factors in wound healing. Ost Wound Manag 1999;45:64-80.
8. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-46.
9. Usuki K, Saras J, Waltenberger J, et al. Protein platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun 1992;184:1311.
10. Bilbo PR, Nolte CLM, Oleson MA, et al. Skin in complex culture: The transition from "culture" phenotype to organotypic phenotype. J Toxicol-Cut Ocular Toxicol 1993;12:183-96.
11. Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf, a human skin equivalent. Cutis 1998;62 (Suppl):1-8.
12. Nolte CJ, Oleson MA, Hansbrough JF, et al. Ultrastructural features of composite skin cultures grafted onto athymic mice. J Anat 1994;185:325-33.
13. Parenteau NL, Nolte CM, Bilbo P, et al. Epidermis generated in vitro: Practical considerations and applications. J Cell Biochem 1991;45:24-51.
14. Briscoe DM, Dharnidharka VR, Isaacs C, et al. The allogenic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection. Transplantation 1999;67:1626-31.
15. Asgari MM, Haggerty JG, McNiff JM, et al. Expression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumors. J Cutan Pathol 1999;26:287-94.
16. Clark RAF. Wound repair: Overview and general considerations. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. New York, NY: Plenum Press, 1996:3-50.
17. Falanga V. Growth factors and chronic wounds: The need to understand the microenvironment. J Dermatol 1992;19: 667-72.
18. Falanga V. Growth factors and wound healing. Dermatol Clin 1993;11:667-75.
19. Ishikawa F, Miyazono K, Hellman U, et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989;338:557-62.
20. Moghaddam A, Zhang HT, Fan TP, et al. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci U S A 1995;92:998-1002.
21. Lee SS, Giovanella BC, Stehlin JS Jr. Selective lethal effect of thymidine on human and mouse tumor cells. J Cell Physiol 1977;92:401-5.
22. Schwartz PM, Kugelman LC, Coifman Y, et al. Human keratinocytes catabolize thymidine. J Invest Dermatol 1988;90:8-12.
23. Usuki K, Heldin NE, Miyazono K, et al. Production of platelet-derived endothelial cell growth factor by normal and transformed human cells in culture. Proc Natl Acad Sci U S A 1989;86:7427-31.
24. Hammerberg C, Fisher GJ, Voorhees JJ, Cooper KD. Elevated thymidine phosphorylase activity in psoriatic lesions accounts for the apparent presence of an epidermal "growth inhibitor," but is not in itself growth inhibitory. J Invest Dermatol 1991;97:286-90.
25. Creamer D, Jaggar R, Allen M, et al. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol 1997;137:851-5.
26. Sabolinski ML, Alvarez O, Auletta M, et al. Cultured skin as a "smart material" for healing wounds: Experience in venous ulcers. Biomaterials 1996;17:311-20.